Global Racecadotril Market Size, Share, Growth, Sale, Price, Insight, Analysis, Trend, Outlook & Forecast 2024-2030
Racecadotril Market

Global Racecadotril Market Size, Share, Growth, Sale, Price, Insight, Analysis, Trend, Outlook & Forecast 2024-2030

The "Global Racecadotril Market " was valued at US$ 222.2 million in 2024 and is projected to reach US$ 360.5 million by 2030, at a CAGR of 8.4% during the forecast period.

Click to learn, How Data-Driven Insights Can Impact your Market Position

Racecadotril is an antidiarrheal medication that works by reducing the excessive secretion of water and electrolytes into the intestines, helping to manage acute diarrhea. It is a prodrug that gets converted into its active form, thiorphan, which inhibits enkephalinase, an enzyme responsible for breaking down endogenous enkephalins. By inhibiting this enzyme, Racecadotril preserves enkephalins, which in turn reduce intestinal hypersecretion without affecting gut motility.

Key features of Racecadotril:

  • Mechanism of action: It acts peripherally in the gut, reducing fluid loss in stools without slowing down bowel movement.
  • Use: Primarily used to treat acute diarrhea, particularly in children and adults.
  • Administration: Available in oral forms like capsules, granules, or suspension.
  • Advantages: It specifically targets intestinal secretion without the constipating effects seen in other antidiarrheal drugs.

Racecadotril is widely used as a supportive treatment to control diarrhea, often alongside rehydration therapy.

Racecadotril Market

The global key manufacturers of Racecadotril include WATERSTONE, TCI AMERICA, MedChemexpress, LGM Pharma, CHEMPACIFIC, Cato Research Chemicals, BOC Sciences, Beta Pharma Scientific and AlliChem, etc. in 2024, the global top five players have a share approximately % in terms of revenue.

Racemicadotril is a neprilyphalin inhibitor, which is a white or off-white crystalline powder that selectively and reversibly inhibits neprilysin, thereby protecting endogenous enkephalins from degradation and prolonging the physiological activity of endogenous enkephalins in the digestive tract.

Racecadotril Market aims to provide a comprehensive presentation of the global market for Racecadotril, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Racecadotril. Racecadotril Market contains market size and forecasts of Racecadotril in global, including the following market information:

  • Global Racecadotril Market Revenue, 2019-2024, 2025-2030, ($ millions)
  • Global Racecadotril Market Sales, 2019-2024, 2025-2030, (K Units)
  • Global top five Racecadotril companies in 2024 (%)

We has surveyed the Racecadotril manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

By Type:

  • Granules
  • Tablets
  • Capsules

By Application:

  • Acute Diarrhea in Adults
  • Diarrhea in Infants Older than 1 Month
  • Acute Diarrhea in Children Older than 30 Months

By Region and Country:

  • North America (United States, Canada, Mexico)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
  • The Middle East and Africa (Middle East, Africa)
  • South and Central America (Brazil, Argentina, Rest of SCA)

Click to learn, How Data-Driven Insights Can Impact your Market Position

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Racecadotril revenues in global market, 2019-2024 (Estimated), ($ millions)
  • Key companies Racecadotril revenues share in global market, 2024 (%)
  • Key companies Racecadotril sales in global market, 2019-2024 (Estimated), (K Units)
  • Key companies Racecadotril sales share in global market, 2024 (%)

Key Players Include:

  • WATERSTONE
  • TCI AMERICA
  • MedChemexpress
  • LGM Pharma
  • CHEMPACIFIC
  • Cato Research Chemicals
  • BOC Sciences
  • Beta Pharma Scientific
  • AlliChem
  • Alchem Pharmtech
  • AKSCI
  • AdooQ BioScience
  • ACC
  • HBCChem
  • APAC Pharmaceutical
  • Shanxi Hanjiang Pharmaceutical
  • Tianjin Weijie Pharmaceutical
  • Hubei Teyer Pharmaceutical
  • Shandong Qidu Pharmaceutical
  • Sichuan Baojian Pharmaceutical

Click to learn, How Data-Driven Insights Can Impact your Market Position

要查看或添加评论,请登录

社区洞察

其他会员也浏览了